Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00532974
What this trial is testing

Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)

Who this might be right for
HIV Infections
Epimmune 32
Post-approval studies (Phase 4)Ended earlyNCT02924389
What this trial is testing

Dolutegravir in Reservoirs

Who this might be right for
HIV
Emory University 22
Not applicableWithdrawnNCT06465862
What this trial is testing

Development of a Silica Microparticle Taggant System to Measure ART Adherence

Who this might be right for
HivMedication AdherenceCompliance, Medication
Brigham and Women's Hospital
Large-scale testing (Phase 3)Study completedNCT03122262
What this trial is testing

ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy

Who this might be right for
HIV-1 Infection
Professor Francois Venter 1,110
Large-scale testing (Phase 3)Study completedNCT01033760
What this trial is testing

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

Who this might be right for
HIV-1 Infections
ANRS, Emerging Infectious Diseases 90
Large-scale testing (Phase 3)Study completedNCT00043888
What this trial is testing

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Who this might be right for
HIV Infections
GlaxoSmithKline 60
Not applicableStudy completedNCT00341796
What this trial is testing

Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India

Who this might be right for
HIV-1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 400
Not applicableStudy completedNCT01038076
What this trial is testing

Medications for Chronic HIV: Education and Collaboration

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeMedication Adherence
Boston University 371
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Post-approval studies (Phase 4)Study completedNCT00054743
What this trial is testing

Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States

Who this might be right for
HIV Infection
National Institutes of Health Clinical Center (CC) 24
Early research (Phase 1)Study completedNCT03329560
What this trial is testing

Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV

Who this might be right for
HIV-1-infection
The University of Texas Health Science Center, Houston 6
Early research (Phase 1)Study completedNCT01546818
What this trial is testing

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

Who this might be right for
HIV Infections
Sumagen 33
Not applicableStudy completedNCT00309582
What this trial is testing

Nevirapine Levels and Fluconazole

Who this might be right for
NevirapineFluconazoleAdverse Event
Bamrasnaradura Infectious Diseases Institute
Not applicableStudy completedNCT01286259
What this trial is testing

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

Who this might be right for
HIV-1 Infection
University of California, San Francisco 16
Early research (Phase 1)UnknownNCT05925140
What this trial is testing

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19Hospitalized COVID-19 Patients
Lebanese University 1,000
Not applicableStudy completedNCT00006290
What this trial is testing

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Study completedNCT01637558
What this trial is testing

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Who this might be right for
TuberculosisHIV
University of Cape Town 200
Testing effectiveness (Phase 2)Study completedNCT00987948
What this trial is testing

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

Who this might be right for
HIV Infections
University of Hawaii 15
Early research (Phase 1)Study completedNCT01433289
What this trial is testing

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Who this might be right for
HIV Infection
Baylor College of Medicine 23
Not applicableNot Yet RecruitingNCT07553949
What this trial is testing

Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics

Who this might be right for
HIV
University of Chicago 465
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation